Maximum Dose of Moxonidine
The maximum recommended daily dose of moxonidine is 0.6 mg per day, typically administered as 0.2 mg three times daily or 0.4 mg once daily with potential titration to 0.6 mg. 1
Dosing Guidelines
Standard Dosing
- Initial dose: 0.2 mg once daily 2
- Usual therapeutic dose: 0.4 mg once daily 2
- Maximum dose: 0.6 mg per day 1
The medication can be administered either as a single daily dose or divided into multiple doses throughout the day. In clinical practice, most patients (67%) successfully maintain blood pressure control with once-daily dosing 3.
Dose Titration
When initiating therapy, start with 0.2 mg daily and increase to 0.4 mg after 1 week if needed. If blood pressure control remains inadequate at 0.4 mg daily, the dose may be increased to the maximum of 0.6 mg daily 1. The titration to effective antihypertensive doses typically occurs within 3 days 3.
Clinical Efficacy at Maximum Dose
Studies demonstrate that moxonidine at 0.6 mg daily produces significant blood pressure reductions, with mean decreases of 17.6/14.5 mm Hg in supine position and 18.2/12.6 mm Hg in standing position 1. Higher doses beyond 0.6 mg have been studied (up to 1.2 mg in pharmacokinetic trials) but are not recommended for routine clinical use 4.
Important Considerations
Combination therapy: Moxonidine is frequently used as adjunctive therapy with other antihypertensives rather than pushing to maximum monotherapy doses. In patients with metabolic syndrome, 81% received combination therapy 5.
Tolerability: The most common side effect is dry mouth, which occurred in approximately 47% of patients but was generally mild and did not require discontinuation 3. At the 0.4 mg dose, moxonidine demonstrates better tolerability than older centrally-acting agents 2.
Metabolic benefits: Beyond blood pressure reduction, moxonidine at therapeutic doses (0.4-0.6 mg) provides favorable effects on metabolic parameters, including weight reduction (mean 1.4 kg over 8 weeks) in obese patients 5.